Tecentriq 1 200 mg concentrate for solution for infusion, Avastin 25 mg/ml concentrate for solution for infusion.
ASPIRE
Phase 2 small_molecule active
Quick answer
Tecentriq 1 200 mg concentrate for solution for infusion, Avastin 25 mg/ml concentrate for solution for infusion. for Patients with resectable hepatocellular carcinoma (amenable R0 resection) at high risk of recurrence. is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Patients with resectable hepatocellular carcinoma (amenable R0 resection) at high risk of recurrence.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active